Lexapro Patent Upheld On Appeal
A federal appeals court panel has upheld both the validity of Forest Laboratories Inc.'s patent on the blockbuster antidepressant drug Lexapro and an injunction thwarting Ivax Pharmaceuticals Corp.'s plans to market...To view the full article, register now.
Already a subscriber? Click here to view full article